Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Autolus Therapeutics plc (NASDAQ: AUTL)
AUTL Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
56.70%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
400%
AUTL Stock Analysis
AUTL
PE Ratio:
AUTL
PEG Ratio:
Not Available
AUTL
Forward EPS Growth (12 month):
0.00%
AUTL
PS Ratio:
4.7
AUTL
PSG Ratio:
0.1
AUTL
Forward Revenue Growth (12 month):
62.50%
AUTL Articles
No data was found